Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 May;77(5):461-4.
doi: 10.1136/hrt.77.5.461.

Cardiac manifestations of acute carbamate and organophosphate poisoning

Affiliations

Cardiac manifestations of acute carbamate and organophosphate poisoning

A M Saadeh et al. Heart. 1997 May.

Abstract

Objective: To study the frequency, extent, and pathogenesis of the cardiac complications accompanying organophosphate and carbamate poisoning.

Design: Retrospective study.

Setting: A medical intensive care unit (MICU) of a general hospital.

Subjects: 46 adult patients admitted over a five year period with a diagnosis of organophosphate or carbamate poisoning.

Results: Cardiac complications developed in 31 patients (67%). These were: non-cardiogenic pulmonary oedema, 20 (43%); cardiac arrhythmias, 11 (24%); electrocardiographic abnormalities including prolonged Q-Tc interval, 31 (67%); ST-T changes, 19 (41%); and conduction defects, 4 (9%). Sinus tachycardia occurred in 16 patients (35%) and sinus bradycardia in 13 (28%). Hypertension developed in 10 patients (22%) and hypotension in eight (17%). Eight patients (17%) needed respiratory support because of respiratory depression. Although more than two thirds of the patients (67%) had a prolonged Q-Tc interval, none had polymorphic ventricular tachycardia of the torsade de pointes type. Two patients died from ventricular fibrillation, an in hospital mortality of 4%.

Conclusions: Cardiac complications often accompany poisoning with these compounds, particularly during the first few hours. Hypoxaemia, acidosis, and electrolyte derangements are major predisposing factors. Intensive supportive treatment in intensive or coronary care facilities with administration of atropine in adequate doses early in the course of the illness will reduce the mortality.

PubMed Disclaimer

Similar articles

Cited by

References

    1. S Afr Med J. 1987 Nov 7;72(9):593-7 - PubMed
    1. Kardiologiia. 1975 Sep;15(9):126-9 - PubMed
    1. N Engl J Med. 1972 Aug 17;287(7):336-8 - PubMed
    1. Can Med Assoc J. 1936 Jan;34(1):9-15 - PubMed
    1. World Health Stat Q. 1990;43(3):139-44 - PubMed

MeSH terms